You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 315 W0180 novel anti-VISTA antibody: Rationale for target patient population and first-in-human trial design in monotherapy and in combination with anti-PD1 antibody

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials in progress
315 W0180 novel anti-VISTA antibody: Rationale for target patient population and first-in-human trial design in monotherapy and in combination with anti-PD1 antibody

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020181047
Dec 202044012
Jan 20214808
Feb 202176014
Mar 2021144016
Apr 20216607
May 20211307
Jun 20210012
Jul 20210014
Aug 20210015
Sep 20210017
Oct 202168030
Nov 202176023
Dec 202166010
Jan 202260010
Feb 20224807
Mar 2022108015
Apr 202284010
May 2022100012
Jun 202286013
Jul 202252010
Aug 202238010
Sep 20229009
Oct 20225607
Nov 20224405
Dec 20225207
Jan 20235802
Feb 20236403
Mar 20238008
Apr 20233606
May 20234603
Jun 20233003
Jul 20234806
Aug 20233904
Sep 202368010
Oct 20234205
Nov 20234805
Dec 20236603
Jan 20245400
Feb 20244400
Mar 202413406
Apr 20246003
May 20249207
Jun 20248304
Jul 20246004
Aug 20242601
Sep 20244801
Oct 20246604
Nov 20246607
Dec 20246903
Jan 202554011
Feb 20251803
Mar 2025403
Apr 2025005
May 2025003
Jun 2025103
Total31040473